Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of Malaria (REACT)
A Cost-effectiveness Analysis of Alternative Strategies for the Deployment of ACTs at the Community Level in Cameroon and Nigeria
Sponsor: London School of Hygiene and Tropical Medicine
Listed as NCT01350752, this NA trial focuses on Malaria and remains completed. Sponsored by London School of Hygiene and Tropical Medicine, it has been updated 6 times since 2011, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London School of Hygiene and Tropical Medicine
- University of Nigeria, Enugu Campus
- University of Yaounde
For direct contact, visit the study record on ClinicalTrials.gov .